
Carlos E. Vargas, MD, discusses research with proton therapy in prostate cancer.

Carlos E. Vargas, MD, discusses research with proton therapy in prostate cancer.

Carlos E. Vargas, MD, examines the use of stereotactic body radiation therapy (SBRT) in oligometastatic prostate cancer.

Carlos E. Vargas, MD, discusses toxicities associated with stereotactic body radiation therapy compared with standard fractionated radiation therapy in prostate cancer.

February 14th 2020